Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 428

1.

Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.

Ravizza R, Gariboldi MB, Molteni R, Monti E.

Oncol Rep. 2008 Sep;20(3):625-30.

PMID:
18695915
2.

NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.

Clark DW, Mitra A, Fillmore RA, Jiang WG, Samant RS, Fodstad O, Shevde LA.

Curr Cancer Drug Targets. 2008 Aug;8(5):421-30.

PMID:
18690848
3.

Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.

Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.

Cell Biochem Biophys. 2009;55(2):95-105. doi: 10.1007/s12013-009-9058-3. Epub 2009 Jul 11.

PMID:
19593673
4.

REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.

Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.

Cancer Gene Ther. 2009 Jan;16(1):65-72. doi: 10.1038/cgt.2008.58. Epub 2008 Jul 25.

PMID:
18654608
5.

Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate.

Calcabrini A, García-Martínez JM, González L, Tendero MJ, Ortuño MT, Crateri P, Lopez-Rivas A, Arancia G, González-Porqué P, Martín-Pérez J.

Carcinogenesis. 2006 Aug;27(8):1699-712. Epub 2006 Apr 19.

PMID:
16624827
6.

Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.

Elmore LW, Di X, Dumur C, Holt SE, Gewirtz DA.

Clin Cancer Res. 2005 Apr 1;11(7):2637-43.

7.

Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1.

Wang MY, Chen PS, Prakash E, Hsu HC, Huang HY, Lin MT, Chang KJ, Kuo ML.

Cancer Res. 2009 Apr 15;69(8):3482-91. doi: 10.1158/0008-5472.CAN-08-2524. Epub 2009 Apr 7.

8.

Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells.

Osbild S, Brault L, Battaglia E, Bagrel D.

Anticancer Res. 2006 Sep-Oct;26(5A):3595-600.

9.

Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.

Joung YH, Lim EJ, Kim MS, Lim SD, Yoon SY, Lim YC, Yoo YB, Ye SK, Park T, Chung IM, Bae KY, Yang YM.

Int J Oncol. 2008 Sep;33(3):477-84.

PMID:
18695876
10.
12.

Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.

Orlandi L, Bearzatto A, Abolafio G, De Marco C, Daidone MG, Zaffaroni N.

Br J Cancer. 1999 Sep;81(2):252-60.

13.

A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.

Shuhendler AJ, Cheung RY, Manias J, Connor A, Rauth AM, Wu XY.

Breast Cancer Res Treat. 2010 Jan;119(2):255-69. doi: 10.1007/s10549-008-0271-3. Epub 2009 Feb 17.

PMID:
19221875
15.

Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets.

Chekhun VF, Lukyanova NY, Kovalchuk O, Tryndyak VP, Pogribny IP.

Mol Cancer Ther. 2007 Mar;6(3):1089-98.

16.

Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.

Al-Ayyoubi S, Gali-Muhtasib H.

Mol Carcinog. 2007 Mar;46(3):176-86.

PMID:
17192871
17.

Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms.

Tophkhane C, Yang S, Bales W, Archer L, Osunkoya A, Thor AD, Yang X.

Int J Oncol. 2007 Oct;31(4):867-74.

PMID:
17786319
18.

Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells.

Alfonso LF, Srivenugopal KS, Arumugam TV, Abbruscato TJ, Weidanz JA, Bhat GJ.

Int J Oncol. 2009 Mar;34(3):597-608.

PMID:
19212664
19.
20.

Supplemental Content

Support Center